Treatment of colorectal cancer: A resolutely multidisciplinary approach;Le traitement du cancer colorectal: Une approche résolument multidisciplinaire

Revue Medicale de Bruxelles

Volumn 22, Issue 6, 2001, Pages 503-512

  Van Laethem, J L ^a   Donckier, V ^a   Demols, A ^a   Franchimont, D ^a   Gay, F ^a   Van de Stadt, J ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Chemotherapy; Colorectal cancer; Hepatectomy; Metastasis; Radiofrequency

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; LEVAMISOLE; ORZEL; OXALIPLATIN; RALTITREXED; TEGAFUR; UFT; URACIL;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PRACTICE; CLINICAL TRIAL; COLORECTAL CANCER; HUMAN; LIVER METASTASIS; PATIENT CARE; QUALITY OF LIFE; RADIOFREQUENCY; SURGICAL TECHNIQUE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ATTITUDE OF HEALTH PERSONNEL; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; COOPERATIVE BEHAVIOR; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; NEOPLASM STAGING; PALLIATIVE CARE; PATIENT CARE TEAM; PROGNOSIS; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0035678386     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Colorectal cancer
2. Prognostic factors in CRC
3. ABC of colorectal cancer: Primary treatment - Does the surgeon matter?
4. Colorectal surgery for cancer: Conventional or laparoscopic?
5. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma
6. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer
7. Clinical trial to assess the relative efficacy of fluorouracil, leucovorin and levamisole in patients with Dukes B and C carcinoma of the colon: Results from National Surgical Adjuvant Breast and Bowel Project C-04
8. Fluorouracil (FU), leucovorin (LV) and levamisole (LEV) adjuvant therapy for colon cancer: Five year final report of INT-089
9. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high risk colon cancer
10. Comparative efficacy of adjuvant chemotherapy in patients with Dukes B versus Dukes C colon cancer: Results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03 and C-04)
11. Efficacy of adjuvant fluorouracil and folinic acid and B2 colon cancer
12. Micrometastases and survival in stage II colorectal cancer
13. Immunohistochemical quantitation of thymidilate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy
14. Microcheler I is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy
15. Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years older
16. Adjuvant chemotherapy for colon cancer is benefitial without significantly increased toxicity in elderly patients: Results from a 3.351 patients metaanalysis
17. Active specific immunotherapy for stages II and III human colon cancer: A randomized trial
18. Monoclonal antibody therapy for resected Dukes C colorectal cancer: Seven year outcome of a multicenter randomized trial
19. Randomized trial comparing monthly low dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer
20. Leucovorin and fluorouracil with or without oxalipalatine as first-line treatment in advanced colorectal cancer
21. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial
22. A phase III trial of Xeloda® (capecitabine) in previously untreated advanced/metastatic colorectal cancer
23. Surgical treatment of adenocarcinoma of the rectum
24. Preoperative adjuvant treatment in rectal cancer. Final results of a randomized study of the EORTC Gastrointestinal Tract Cancer Cooperative Group
25. The mesorectum in rectal cancer surgery. The clue of pelvic recurrence
26. Improved survival with preoperative radiotherapy in resectable rectal cancer
27. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable advanced rectal cancer
28. Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil with radiation therapy after curative surgery
29. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial
30. Randomised comparison of combination therapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer
31. Final results of a randomised trial comparing Tomudex® (raltitrexed) with 5-FU plus leucovorin in advanced colorectal cancer
32. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure for patients with metastatic colorectal cancer
33. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer
34. Evaluation of the addition of oxaliplatin to the same Mayo or German 5FU regimen in advanced refractory colorectal cancer
35. Resection of non resectable liver metastases from colorectal cancer after neoadjuvant chemotherapy
36. Longterm survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery
37. The natural history of primary and secondary malignant tumours of the liver
38. Cote results justify resection for multiple hepatic metastases from colorectal cancer
39. Hepatic resection for colorectal liver metastases: Influence on survival of preoperative factors and surgery for recurrences in 80 patients
40. Surgical resection of colorectal carcinoma metastases in the liver. A prognostic system to improve case selection, based on 1.568 patients
41. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer
42. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: Results in 123 patients
43. Radiofrequency ablation for malignant liver tumors: Contribution of the PET-scan in the pre and postoperative evaluation